Carbapenem-resistant Providencia spp.: the threat at the door

Onur Ozalp1, Baran Ortakci1, Selda Komec2

  • 1Department of Infectious Diseases and Clinical Microbiology, Basaksehir Cam and Sakura Hospital, University of Health Sciences, Istanbul, Turkey.

Abstract

Insights

Carbapenem-resistant Providencia infections, often caused by P. rettgeri, lead to worse outcomes and higher mortality. Strengthening infection control and antimicrobial stewardship is crucial for managing these challenging nosocomial infections.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Providencia species are increasingly recognized as opportunistic nosocomial pathogens.
  • Carbapenem-resistant Providencia spp. present a significant therapeutic challenge due to limited treatment options.

Purpose of the Study:

  • To evaluate clinical characteristics, risk factors, and outcomes of carbapenem-resistant versus carbapenem-susceptible Providencia spp. infections.
  • To identify independent risk factors associated with carbapenem resistance in Providencia isolates.

Main Methods:

  • Retrospective observational study of hospitalized patients with Providencia spp. isolates (2020-2024).
  • Stratification of patients based on carbapenem susceptibility.
  • Comparison of clinical data, risk factors, and mortality rates between resistant and susceptible groups.

Main Results:

  • 44.9% of 118 Providencia infections were carbapenem-resistant, predominantly P. rettgeri.
  • Carbapenem-resistant infections were linked to longer hospital stays, ICU admissions, and higher mortality.
  • Risk factors for resistance included prior ICU admission, mechanical ventilation, urinary catheterization, and prior carbapenem use.

Conclusions:

  • Carbapenem-resistant Providencia infections are associated with increased morbidity and mortality.
  • Enhanced infection control and antimicrobial stewardship are essential.
  • Further research is needed on resistance mechanisms and optimal treatment strategies.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
220
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
175
Antibiotic Selection00:57

Antibiotic Selection

Overview
55.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
97
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
456